Diazepam

Producers shown on SFDA

(Record date:06/09/2021）

Producers shown on EP

(Quoted from EP website；record date:06/09/2021）

Producer:Shanxi Xinbaoyuan Pharmaceutical Co., Ltd. was established in 2004 with a registered capital of 100 million yuan and a total asset of 480 million yuan. It covers an area of about 130000 square meters. It is a comprehensive pharmaceutical enterprise integrating drug R & D, production and sales.

With advanced equipment and strong technical force, the company has a national production base of "methyl ester series" of antibiotic pharmaceutical intermediates and a complete industrial chain from raw materials to agent production based on independent research and development of "pectin". The product categories include pharmaceutical intermediates, oral APIs, isomorphic preparations, penicillin, etc., with more than 100 product approvals. Among them, 3 products have independent R & D patent certificates and enjoy exclusive patent use rights, and another 7 products have obtained national new drug certificates. The efficacy of the product covers many fields such as digestive system, pediatrics, respiratory system and local anesthesia.

Registered capital:RMB 100 million

Producer:Shanghai Anding Biological (Tangyin) Pharmaceutical Co., Ltd., established in 2012, covers the production and sales of tablets, hard capsules, granules, oral emulsions (anti-tumor), psychotropic drugs (diazepam tablets), Bacillus subtilis, Saccharomyces cerevisiae and health care products.
Staff size:/

Registered capital:RMB 30 million

Producer:Huazhong Pharmaceutical Co., Ltd. is subordinate to China Ordnance Equipment Group Corporation. It is located in Xiangyang City, an important town in Northwest Hubei Province with beautiful scenery and rich resources. It covers an area of 700000 square meters. It is a modern comprehensive pharmaceutical enterprise integrating R & D, production and sales of pharmaceutical products. The company has strong technical force, complete quality testing equipment and quality assurance system, advanced production technology and equipment, and has passed GMP, fami-qs, HACCP, ISO9001, ISO22000, kosher, halal and other certifications.

Subsidiaries of Huazhong Pharmaceutical Co., Ltd.: Hubei 295 Technology Co., Ltd. and Xiangfan 295 Pharmaceutical Trading Co., Ltd. We are the earliest manufacturer of vitamin B1 raw materials in China and the largest in the world. The product quality meets the quality standards of CP, BP, USP, EP and JP. At the same time, we have also developed VB1 Granule Series and VB1 derivative series products.

Staff size:600-699 persons

Registered capital:RMB 245 million 148 thousand and 515

Producer:Sancai Shiqi Pharmaceutical Co., Ltd. (formerly Guangdong Sancai Shiqi Pharmaceutical Co., Ltd.) is a modern professional pharmaceutical group integrating scientific research, production, sales, logistics, retail terminal and medical treatment.
Staff size:100-199 persons

Registered capital:RMB 50 million

Producer:Hebei Changtian Pharmaceutical Co., Ltd., founded in 1947, now has 132 national registered production variety numbers in 6 categories, including tablets, capsules, granules, APIs, sterile APIs and traditional Chinese medicine preparations. In 2004, a new production base of 160 Mu was completed, which can produce 2 billion tablets, 120 million injections, 500 million capsules, 700 million bags of granules, 100 million bags of small powder, 500000 bags of large powder, 60 tons of Artificial Cordyceps mycelium powder, 30 tons of sodium fructose diphosphate, 30 tons of calcium fructose diphosphate, 20 tons of artificial bezoar, 10 tons of Coriolus Versicolor Polysaccharide, 4.5 million pieces of sodium fructose diphosphate injection and 1200 tons of traditional Chinese medicine extraction.
Staff size:400-499 persons

Registered capital:RMB 30 million

Producer:Changzhou siyao Pharmaceutical Co., Ltd. has passed the three management system certification of national drug GMP, international environmental management ISO14001 and international occupational health and safety OHSMS18001, and three products have passed the certification of FDA and CEP of the European Union.

Current production capacity: 25 raw material intermediates, 100 tons, of which 50 tons are self exported; 20 million lyophilized powder needles and 100 million water needles; 2 billion capsules, tablets and controlled and sustained release preparations; 20 million creams and new transdermal patches.

Registered capital:USD 7.08 million

Producer:Sinopharm Group Xinjiang Pharmaceutical Co., Ltd., established in 1958, has two preparation workshops and two comprehensive extraction workshops meeting GMP standards. It mainly produces 292 varieties and specifications of preparations and APIs in 13 dosage forms, such as large volume injection preparations, small volume injection preparations, tablets, capsules, granules, pills, oral liquids, syrups, mixtures and decoctions.
Staff size:300-399 persons

Registered capital:RMB 90.964 million

Producer:Beijing Yimin Pharmaceutical Co., Ltd. (formerly Beijing Yimin pharmaceutical factory) was founded in 1968, covering an area of 60000 square meters and a construction area of 28000 square meters. Yimin pharmaceutical has advanced production systems (including API, solid oral preparation, hormone production line, cephalosporin production line, injection production line, etc.), complete quality testing system and high-quality employees.

Staff size:200-299 persons

Registered capital:RMB 5.18 million

Producer:Shandong Xinyi Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise integrating manufacturing, sales and R & D, jointly funded by Shanghai Xinyi Pharmaceutical Factory Co., Ltd., a wholly-owned subsidiary of Shanghai Pharmaceutical Group Co., Ltd., Shandong Pingyuan pharmaceutical factory and Dezhou Borun Pharmaceutical Technology Co., Ltd.

Staff size:200-299 persons

Registered capital:RMB 17740.615851 million